XJPX
5133
Market cap30mUSD
Jul 10, Last price
312.00JPY
1D
1.63%
1Q
-2.50%
IPO
-4.29%
Name
Terilogy Holdings Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Terilogy Holdings Corporation, established in Tokyo, Japan, in 1989 (initially as Terilogy Co., Ltd.), specializes in providing a comprehensive range of IP network and cybersecurity products and solutions to businesses across Japan and globally. The company's diverse portfolio includes the distribution and sale of essential network hardware and software, such as routers, switches, wireless LAN technology, and DNS/DHCP systems. They offer complete service packages, from system consulting, integration, and end-user training, to network construction, implementation, and continuous maintenance, alongside developing bespoke application software. A significant area of expertise is network security, where Terilogy supplies robust firewalls, intrusion detection and prevention systems, data leakage prevention tools, and secure authentication solutions, including one-time password systems. For network optimization and diagnostics, they provide support tools like packet capture and application performance monitoring products. Their proprietary innovations include EzAvater, a software-based robotic process automation (RPA) tool, and CloudTriage, a cloud-native service dedicated to monitoring application performance. Terilogy also offers tailored network services for small and medium-sized enterprises (SMEs), encompassing real-time video interpretation, managed VPNs, web conferencing, business internet access, high-speed mobile data communication, and rental server solutions. Furthermore, the company's capabilities extend to designing internal corporate communication networks and general infrastructure, deploying teleconferencing systems, and delivering thorough after-sales maintenance. Their primary client base includes manufacturers and telecommunications carriers.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||